A case of recurring spinal ependymoma in 37-years old man after surgery and adjuvant therapy
Abstract
We present the case of a 39-years old man who underwent three surgeries because of spinal ependymoma located in cauda equina region. He presented at the Oncology Institute of Vojvodina for combined adjuvant chemo- and radiotherapy after the second surgery. An MRI examination performed after six cycles of therapy showed no signs of disease. 26 months later, a follow-up MRI showed recurrence of disease in the form of small drop metastasis. Six months later, the patient underwent the third surgery. The patient is currently receiving another cycle of radiotherapy, and is scheduled for additional cycles of chemotherapy. Ependymomas are the most common spinal cord malignancy in adults. The symptoms are nonspecific which often causes a delay in diagnosis. An MRI examination of the spine with contrast admission is the study of choice for detecting spinal cord masses. Surgery is the first-line therapy for ependymomas. Recurrence rate is associated with the extent of surgical resection, with en bloc and gross-total resection being associated with lower rates of disease recurrence. In children under 3 years, adjuvant chemotherapy is advocated, while older children and adults undergo adjuvant radiotherapy or combined chemo- and radiotherapy in cases of subtotal resection or tumor recurrence.
References
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A, editors. WHO Classification of Tumours of the Central Nervous System. Revised 4th ed. Lyon (France): IARC Press; 2016.
Abdelzaher E. Ependymoma [Internet]. Bingham Farms (MI): PathologyOutlines; 2012 Aug 1 [revised 2019 Nov 22; cited 2020 Feb 6]. Available from: https://www.pathologyoutlines.com/topic/cnstumorependymoma.html
Dahnert W. Radiology review manual. 6th edition. Philadelphia: Lippincott Williams Wilkins; 2007.
Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro Oncol 2016;18:902–13.
Warren K. Ependymomas [Internet]. Germantown (MD): The Childhood Brain Tumour Foundation. [cited 2020 Feb 6]. Available from: https://www.childhoodbraintumor.org/medical-information/braintumor-types-and-imaging/item/84-ependymomas.
Celano E, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis C. Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neurooncol. 2016 July;128(3):377–386.
Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the Spinal Cord and Filum Terminale: Radiologic-Pathologic Correlation. RadioGraphics. 2000;20(6):1721–49.
Wild F, Hartmann C, Heissler HE, Hong B, Krauss JK, Nakamura M. Surgical Treatment of Spinal Ependymomas: Experience in 49 Patients. World Neurosurg. 2018;111.
Abdulaziz M, Mallory GW, Bydon M, Ramos RDLG, Ellis JA, Laack NN, et al. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity. Neurosurg Focus. 2015;39(2).
Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T, et al. Is gross-total resection sufficient treatment for posterior fossa ependymomas? J Neurosurg. 2005;102(4):629-36
Reni M, Gatta G, Mazza E, Vecht C. Ependymoma. Crit Rev Oncol Hematol. 2007;63(1):81-9
Oh MC, Tarapore PE, Kim JM, Sun MZ, Safaee M, Kaur G, et al. Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci. 2013;20(10):1390–1397.
Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, et al. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol. 2013;15:208–215.
Nagasawa DT, Smith ZA, Cremer N, Fong C, Lu DC, Yang I. Complications associated with the treatment for spinal ependymomas. Neurosurg Focus. 2011;31:E13.
